The Bioscience Brief

Welcome to the national bioscience newsletter dedicated to communicating with you what is going on in the exciting bioscience industry. Over the last five years there have been more than 45 Bioscience Business Roundtable (BBR) forums across the country with the bioscience community and public policy makers. Our mission is to promote public policies that on a local, state, and federal level safeguard and sustain America's place as the world leader in bioscience. Congress is currently considering issues of great importance to the bioscience community: intellectual property protection, capital investment, workforce issues, FDA reform and price controls. Our goal is to ensure the voices of the bioscience community are heard as these issues are debated. You have received this newsletter as a result of your RSVP to one of our forums. The brief is made possible through support from national partners including: the Biotechnology Industry Organization (BIO), the National Venture Capital Association (NVCA), the Pharmaceutical Research and Manufacturers of America (PhRMA), and the United States Chamber of Commerce.

Thank you,
Bioscience Brief Staff

PhotoBioscience Business Roundtable Unveils New Site

The Bioscience Business Roundtable (BBR) national partnership recently announced a new state of the art website as part of the rebranding of the successful Biz-Bio program.

"We're thrilled to have this tool to communicate the successes and challenges within the bioscience community," said Frank Howard, Executive Director of BBR. "The website is a platform to help us communicate in a clear and unified voice on issues; promote qualitative and quantitative information to decision-makers; and advance policies to support the ongoing development and growth of a vibrant bioscience industry."

Please visit our new website's Take Action section to communicate critical bioscience information to your local elected officials here: http://nationalbbr.org/takeaction

2009 Going Strong: Bioscience Business Roundtables Held In Five States
Three More Events Draw Near

2009 has been an excellent year for the bioscience industry as relationships between professionals, legislators and educators have been forged at the BBR forums that have taken place so far in New York, Texas, Delaware, California and Colorado. Coming later this year are BBR forums in Connecticut, Washington and Virginia.

Albany, New York – February 2, 2009: New York's third BBR event, "Fighting for a Healthy Biotech Industry," was held in the Concourse of the New York State Capitol Building. In attendance were senior staff from critical New York State Senate committees, CEOs and Presidents of local biotech companies, members of the New York State PhRMA task force, venture capitalists, legal professionals, academics and media. Gov. PerryThe event's panelists and speakers focused on the promise of a healthy biotech industry in New York and its potential for driving economic development and providing well paying jobs for New York's graduating students.

Austin, Texas – February 17, 2009: The "Texas Life Science Industry: Competing in a Global Economy" event was held at the Omni Austin Hotel in downtown Austin. The event focused on the future of the bioscience and pharmacological community in Texas. The conference was organized to coincide with Texas Technology Week, which is an opportunity for emerging technology industries to showcase strengths and discoveries while championing legislation to help the research and development environment in Texas. A distinguished audience of over 150 attendees was joined by Governor Rick Perry (pictured above right); staff from the Governor's and state legislators' offices; local economic development leaders including Chamber of Commerce representatives; bioscience company professionals; academic leaders and researchers; and members of the media.

Gov. MarkellNewark, Delaware – August 12, 2009: Delaware's BBR event featured Governor Jack Markell (pictured left) as the event's closing speaker. Representatives from Delaware's diverse academic, bioscience, venture capital, business, government and media sectors gathered at the John H. Ammon Medical Center. The event boasted more than 200 attendees and panelists. Speakers covered a range of issues including capital investment, intellectual property protection, workforce issues and FDA reform. Speakers were optimistic about bioscience growth in Delaware and the event was an opportunity for strategic partnerships to form between government, academia and industry. The event was covered on the front page of the Wilmington News Journal.

Menlo Park, California – August 26, 2009: With Silicon Valley's position as a world leader in technology and the economic difficulties presently facing the State of California, California is in a unique position and fully embraced the BBR event. The Acting Secretary for California's Labor and Workforce Development Agency spoke at the event as did the Deputy Secretary for California's Health and Human Services Agency and California's Chairman and Vice-Chairman of the Select Committee on Biotechnology. In addition, the event attracted lawmakers from out of state including Majority Leader Adam Hasner of the Florida House of Representatives. The event also attracted attendees with influence in California's education, business and governmental spheres. Discussion at the forum ranged from health care reform efforts under debate by the Obama Administration and Congress to local tax policies that could improve the climate for Panelbusinesses in California and draw new investors to the bioscience community. Speakers discussed what it takes to innovate and realistically bring a new drug to market.

Denver, Colorado – September 1, 2009: Bioscience investment in Colorado is one of Governor Ritter's top five state economic development priorities and this BBR event boasted more than 250 attendees and fifteen state legislators. The event featured Representative Jim Riesberg, a leader in the bioscience community who has successfully passed legislation in support of the biosciences. Health care reform efforts, local tax policies that could improve the economic climate for business in Colorado, and efforts to draw new investors to the bioscience community were some of the many topics discussed at the event. Colorado's BBR event additionally featured a local "Innovation Showcase" which allowed attendees to hear stories from three companies' research successes including a revolutionary heart valve system, stem cell repair of skeletal muscle, and treating medically refractory neurological conditions. The event also featured Reid Wilson, from The Hill newspaper in Washington, D.C., the largest-circulating of all Capitol Hill newspapers, speaking on health care reform from a reporter's front row seat, making this event especially timely.